RecruitingNCT03000244

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation


Sponsor

National Cancer Institute (NCI)

Enrollment

2,000 participants

Start Date

Apr 26, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Background: People who have had an allogeneic hematopoietic stem cell transplant (HCT) have bone marrow or an immune system that is damaged. They get stem cells from a donor who is a relative. Researchers want to study stem cell donors and recipients to learn about the long-term effects of HCT. They want to learn how the stem cells change and how to improve their ability to fight cancer. Objective: To provide long-term follow-up care for people who underwent or will undergo HCT. To collect data, blood, and tissue samples to learn about late complications after HCT. Eligibility: Adults age 18 and older who will undergo HCT or underwent HCT and are surviving one year or more from the date of HCT. The stem cell donors for these recipients are also needed. Design: Recipients will have 1 visit each year. They will have a physical exam. They will answer questions about their medical history and health. They will receive screening and surveillance testing. They will complete brief questionnaires. Recipients will have blood tests. They may have tissue biopsies or specimens (such as tissue in their cheek or skin or bone marrow biopsy). Recipients will give their current address and phone number, and the same data for one or two other people, who can get in contact with them. After the first visit at the clinic, some recipients may see a doctor close to home to get the necessary information and send it to NIH. Donors will come to the clinic for 1 visit. They will answer questions about their medical history. Blood samples will be taken.


Eligibility

Min Age: 4 Years

Plain Language Summary

Simplified for easier understanding

This long-term follow-up study tracks the health of people who have had a hematopoietic stem cell transplant (bone marrow transplant) and are now at least one year post-transplant. Researchers monitor for late complications including organ problems, secondary cancers, and quality of life issues that can emerge years after transplant. You may be eligible if: - You received a bone marrow or stem cell transplant for any reason (cancer or non-cancer condition) - You are at least 1 year out from your transplant date - You are 4 years of age or older - You have a primary physician within the United States - Stem cell donors of enrolled patients and parents of enrolled children may also participate You may NOT be eligible if: - Your original disease has relapsed, or you have developed a new blood cancer or post-transplant lymphoproliferative disorder (PTLD) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03000244


Related Trials